DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 18 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $182,000 | -38.5% | 42,887 | -59.5% | 0.15% | -18.1% |
| Q1 2020 | $296,000 | -50.1% | 105,842 | -13.4% | 0.18% | -37.2% |
| Q4 2019 | $593,000 | +101.7% | 122,156 | -13.9% | 0.29% | +72.6% |
| Q3 2019 | $294,000 | -55.3% | 141,801 | +7.0% | 0.17% | -53.8% |
| Q2 2019 | $657,000 | +20.8% | 132,514 | +10.6% | 0.36% | +20.1% |
| Q1 2019 | $544,000 | +44.3% | 119,863 | -7.7% | 0.30% | +6.3% |
| Q4 2018 | $377,000 | – | 129,863 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |